Qualigen Therapeutics’ Partner NanoSynex to Present Technology at BioMed Israel
10 mai 2022 09h17 HE
|
Qualigen Therapeutics, Inc.
Innovative Technology Aims to Accelerate Antimicrobial Susceptibility Test Result Times by Six-Fold CARLSBAD, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a...